Accessibility Menu
Coloplast A/s logo

Coloplast A/s(OTC) CLPBF

Market Cap$15.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2004)-32%
5 Year-58%
1 Year-27%
1 Month+7%
$68.33
+3.09%
+2.04Today
Coloplast A/s last closing stock price
MetricPriceDate
Last closeUSD 68.332026-08-20
Coloplast A/s stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+5.08%USD 65.022026-08-12
1 month+6.76%USD 64.002026-07-21
3 month+8.45%USD 63.002026-05-22
Year to date-17.31%USD 82.622025-12-24
1 year-27.01%USD 93.612025-08-20
3 year-34.41%USD 104.162023-08-17
5 year-57.53%USD 160.872021-08-16
Since inception-31.62%USD 99.922004-12-06

Coloplast A/s Financials at a Glance

Market Cap

$15.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

DKK 28.41B

Net Income (TTM)

DKK 2.76B

EPS (TTM)

$1.91

P/E Ratio

35.80

Dividend

$3.58

Beta (Volatility)

0.21 (Low)

Price

$68.33

Volume

39

Open

$68.33

Previous Close

$68.33

Daily Range

$68.33 - $68.33

52-Week Range

$56.81 - $98.58

Estimated Earnings Date

Nov 3, 2026

CLPBF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Coloplast A/s

Coloplast A/S is a leading global company specializing in the development and sale of intimate healthcare products and services. Founded in 1954 and headquartered in Humlebæk, Denmark, the company operates across various segments, including Chronic Care, Continence Care, and Advanced Wound Dressings.

Products and Services
  • Ostomy care products, including SenSura Mio and Brava accessories
  • Continence care solutions like SpeediCath catheters and Peristeen irrigation systems
  • Advanced wound care products, including Biatain Silicone and Comfeel dressings
Growth Outlook
  • Revenue of DKK 7.33 billion in Q3 2026, showing strong demand
  • Net income of DKK 1.46 billion in Q3 2026, indicating profitability
  • Consistent investment in R&D, with DKK 280 million allocated in Q3 2026
Financial Highlights
  • Trailing twelve months (TTM) revenue of DKK 28.5 billion, reflecting robust growth
  • Net profit margin of 9.71% TTM, showcasing operational efficiency
  • Dividend yield of 5.28% TTM, appealing for income-focused investors
Coloplast A/S has established itself as a key player in the healthcare sector, focusing on innovative solutions for patients with intimate healthcare needs. The company's diverse product portfolio addresses various medical conditions, ensuring a steady demand for its offerings. Recent financial performance highlights a strong revenue trajectory and profitability, supported by strategic investments in research and development. The company's commitment to innovation and quality positions it well for future growth, making it an attractive option for potential investors.
AI Generated • Aug 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

16,907

CEO

Gavin Wood, MBA

Website

www.coloplast.com

Headquarters

Humlebæk, ZE 3050, DK

CLPBF Financials

Key Financial Metrics (TTM)

Gross Margin

58.50%

Operating Margin

26.35%

Net Income Margin

9.71%

Return on Equity

19.69%

Return on Capital

19.55%

Return on Assets

5.89%

Earnings Yield

2.79%

Dividend Yield

5.24%

Payout Ratio

1.88%

Stock Overview

Market Cap

$15.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

225.37M

Volume

39

Avg. Volume

1.05K

Financials (TTM)

Gross Profit

DKK 17.42B

Operating Income

DKK 7.46B

EBITDA

DKK 11.77B

Operating Cash Flow

DKK 7.66B

Capital Expenditure

-DKK 1.40B

Free Cash Flow

DKK 6.26B

Cash & ST Invst.

DKK 814.09M

Total Debt

DKK 23.72B

Coloplast A/s Performance Analysis

Coloplast A/s annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30DKK 3,282,245,3135.2%
20232023-09-30DKK 3,507,139,8256.9%
20242024-09-30DKK 3,928,316,42412.0%
20252025-09-30DKK 4,124,716,4405.0%
Coloplast A/s sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30-0.2%
Q12025-12-311.4%
Q22026-03-310.7%
Q32026-06-303.3%
Coloplast A/s annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30DKK 3.21-11.6%
20232023-09-30DKK 3.18-1.2%
20242024-09-30DKK 3.262.8%
20252025-09-30DKK 2.39-26.9%
Coloplast A/s sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-308.7%
Q12025-12-3159.8%
Q22026-03-31-169.5%
Q32026-06-30250.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

DKK 7.33B

+5.3%

Gross Profit

DKK 4.89B

+3.9%

Gross Margin

66.73%

N/A

Market Cap

$15.40BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$910.76K

N/A

Employees

16,907

N/A

Net Income

DKK 1.46B

+81.0%

EBITDA

DKK 2.26B

+3.9%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

DKK 814.09M

+12.1%

Total Debt

DKK 23.72B

-2.1%

Accounts Receivable

DKK 5.05B

-5.3%

Inventory

DKK 4.12B

+9.0%

Long Term Debt

DKK 20.85B

+20.7%

Short Term Debt

DKK 2.87B

-58.7%

Return on Assets

5.89%

N/A

Return on Invested Capital

18.61%

N/A

Free Cash Flow

DKK 1.44B

+19.1%

Operating Cash Flow

DKK 1.70B

+4.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SBHMYSino Biopharmaceutical Limited
$13.86+6.53%
SUVPFSartorius AG
$270.29+0.00%
SAUHYStraumann Holding AG
$11.77-0.17%
SAUHFStraumann Holding AG
$118.73+4.15%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About CLPBF

What is the current price of Coloplast A/s?

Coloplast A/s is trading at $68.33 per share.

What is the 52-week range for Coloplast A/s?

Over the past 52 weeks, Coloplast A/s has traded between $56.81 and $98.58.

How much debt does Coloplast A/s have?

As of the most recent reporting period, Coloplast A/s reported total debt of DKK 3.64B.

How much cash does Coloplast A/s have on hand?

Coloplast A/s reported DKK 124.96M in cash and cash equivalents in its most recent financial results.

What is Coloplast A/s’s dividend yield?

Coloplast A/s currently has a dividend yield of 5.24%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services